Vancouver, BC, January 27, 2025 – TheNewswire - TAAT Global Alternatives, Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT”) announces that it has entered into a binding definitive agreement with Premium Products LLC (“Premium Products”) dated January 27, 2025, under which TAAT will acquire a 100% equity interest in Premium Products. Pursuant to the January 17, 2025 announcement of entering into a non-binding Letter of Intent, the Company conducted due diligence, finalized negotiations and documented the framework of an acquisition transaction. The transaction is anticipated to close in early February 2025 and is subject to all shareholders of Premium Products (the "Vendors") agreeing to be bound by the definitive agreement, and to applicable filings with the Canadian Securities Exchange (the “CSE”).

Premium Products is an emerging distributor in the alternative product space. This acquisition aligns with TAAT’s strategic objectives to diversify its product offerings, tap into new market opportunities, and accelerate revenue growth within the consumer-packaged goods (CPG) sector. Premium Products have a diverse product portfolio through its Delta-9 offerings which include chocolates, gummies, and disposable vape devices.  Premium Products have also developed partnerships to bring other innovative products to market, including non-tobacco nicotine alternatives and wellness-focused beverages, reinforcing its position in the alternative product space.

Consideration for the acquisition of Premium Products will be 10,882,353 common shares of the Company issued at a deemed price of $0.17 per share (the “Consideration Shares”). The Consideration Shares will be subject to the statutory four (4) month and one (1) day hold period from issuance. Upon completion of the transaction, Premium Products will operate as a wholly owned subsidiary of TAAT. The Vendors are arm’s-length parties to the Company.

No finder’s fees will be payable in connection with the closing of the acquisition.

None of the securities issued in connection with the acquisition of Premium Products will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none of them will be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.

The acquisition remains subject to receipt of all necessary regulatory approvals, including, as applicable, all required filings with the Canadian Securities Exchange. The acquisition will not constitute a fundamental change, within the meaning of the policies of the CSE.

TAAT’s Continued Organic Growth

TAAT continues to experience demand for its Beyond Tobacco™ cigarettes, which provide a nicotine- and tobacco-free smoking experience. This trend reflects broader consumer preferences for wellness-focused alternatives, particularly among adult smokers seeking healthier options. The acquisition enhances TAAT’s ability to deliver a broader range of alternative products to meet evolving consumer demands.

On behalf of the Board of Directors of the Company,

TAAT® GLOBAL ALTERNATIVES INC.

 

“Joel Dumaresq”

 

Joel Dumaresq, CFO and Director

 

For further information, please contact:

 

TAAT® Investor Relations

1-604-687-2038

investor@taatglobal.com

 

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

About TAAT Global Alternatives, Inc.

TAAT is a consumer product company specializing in innovative alternatives to traditional CPG categories. With a commitment to quality and consumer satisfaction, TAAT operates from its Ohio distribution center, fulfilling orders and supporting a growing network of retail locations across the U.S.

For additional information, visit taatglobal.com 

Forward-Looking Statements

Certain information contained herein may constitute "forward-looking information" or "forward-looking statements" under Canadian securities legislation. Generally, forward-looking information can be identified by words such as "pro forma", "plans", "expects", "may", "should", "could", "will", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes", or variations including negative variations thereof of such words and phrases that refer to certain actions, events or results that may, occur or be taken or achieved. Such forward-looking statements, including but not limited to statements relating to the expected development and operations of the Company, including market conditions, regulatory developments and the successful integration and performance of Premium Products LLC within TAAT’s broader operations which  involve risks, uncertainties and other factors which may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Corporation will not update any forward-looking statements or forward-looking information included herein, except as required by applicable securities laws.

 

The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.

 

This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.

 

Statement Regarding Third-Party Investor Relations Firms

 

Disclosures relating to investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the Company's profile on www.sedarplus.ca.